PSYCHEMEDICS CORP·4

Aug 21, 5:48 PM ET

Hullinger Brian 4

4 · PSYCHEMEDICS CORP · Filed Aug 21, 2023

Insider Transaction Report

Form 4
Period: 2023-08-17
Hullinger Brian
DirectorPresident & CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-08-17+100,000100,000 total
    Exercise: $4.64Exp: 2033-08-17Common Stock, $.005 Par Value (100,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-08-17+200,000200,000 total
    Exercise: $4.64Exp: 2033-08-17Common Stock, $.005 Par Value (200,000 underlying)
Footnotes (2)
  • [F1]The option becomes exercisable with respect to 50% of the shares on August 17, 2024 and with respect to the remaining 50% on August 17, 2025.
  • [F2]The option becomes exercisable, if at all, in two 100,000 share increments if the weighted average daily price of Psychemedics Corporation's common stock on the Nasdaq Stock Market during any 60 consecutive calendar day period exceeds $5.50 and $6.50, respectively.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES